Calithera Biosciences, Inc.
Calithera Biosciences, Inc.（CALA）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
cala · 股价预测 · 10 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 10 位华尔街分析师
Buy
10 位分析师
共识
评级分布
12 个月目标价
High
$2.00
Consensus
$2.00
+666566.6% upside
Low
$2.00
Median: $2 · Last Close: $0.00
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $0.00 | ↑ 0.00% |
1-day model range: $0–$0. Peak: $0 (+0.00%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · CALA · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2022-11-15 | SVB Leerink | Downgrade ↓ | Outperform→Market Perform |
| 2022-11-15 | Ladenburg Thalmann | Downgrade ↓ | Buy→Neutral |
| 2022-08-29 | HC Wainwright & Co. | Upgrade ↑ | Neutral→Buy |
| 2022-08-16 | SVB Leerink | Maintains | Outperform→Outperform |
| 2022-05-11 | Wells Fargo | Maintains | Equal Weight→Equal Weight |
| 2022-04-04 | SVB Leerink | Maintains | Outperform→Outperform |
| 2022-01-31 | Ladenburg Thalmann | Maintains | Buy→Buy |
| 2022-01-20 | SVB Leerink | Upgrade ↑ | Market Perform→Outperform |
| 2021-11-08 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2021-11-05 | William Blair | Downgrade ↓ | Outperform→Market Perform |
Wall Street analysts have recently issued updated ratings on Calithera Biosciences, Inc. (CALA) stock. Of the recent 29 rating actions, 4 were upgrades and 5 were downgrades. 10 analysts currently cover CALA.
分析师推荐趋势
CALA analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 0 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$0M
Revenue Next Year
$5M
EPS This Year
$-8.62
EPS Next Year
$-5.00
↓ 42.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast CALA EPS of $-8.62 for the current fiscal year, based on estimates from 1 analysts. The CALA revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
CALA 股价预测由两类独立数据源支撑：来自 10 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。CALA 的共识目标价为 $2.00（+666566.6% 上行空间），分析师共识为 Buy。
CALA 的短期预测（明日）为 $0.00（+0.00%）。
Calithera Biosciences, Inc. 在 OTC 上市，代码 CALA。CALA 在 2027 年的整体展望偏积极，在覆盖分析师中约 60% 对应 Buy 共识。
常见问题
CALA 预测 · 8 个问题根据 10 位华尔街分析师，CALA 的 12 个月平均目标价为 $2.00，最高 $2.00、最低 $2.00。若有图表，中位目标价可在上方查看。相对当前价 $0.00，隐含约 +666566.6% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.